Literature DB >> 29588531

Review of case reports on hyperkalemia induced by dietary intake: not restricted to chronic kidney disease patients.

Rogier P M Te Dorsthorst1, Jytte Hendrikse1, Mats T Vervoorn1, Valerie Y H van Weperen1, Marcel A G van der Heyden2.   

Abstract

Hyperkalemia is a metabolic disturbance of the potassium balance that can cause potentially fatal cardiac arrhythmias. Kidney dysfunction and renin-angiotensin-aldosterone system inhibiting drugs are notorious for their tendency to induce hyperkalemia by decreasing the excretion of potassium. The role of dietary potassium intake in inducing hyperkalemia is less clear. We review and analyze the common presentation, laboratory, and electrocardiogram (ECG) findings and therapeutic options associated with dietary-induced hyperkalemia, and find evidence for hyperkalemia development in non-renal impaired patients. Thirty-five case reports including 44 incidences of oral intake-induced hyperkalemia were assessed, 17 patients did not suffer from kidney dysfunction. Mean age was 49 ± 20 years. Mean potassium concentration was 8.2 ± 1.4 mEq/l, most frequently caused by abundant intake of fruit and vegetables (n = 17) or salt substitutes (n = 12). In patients with normal kidney function, intake of salt substitutes or supplements was the main cause of hyperkalemia. Main symptoms encompassed muscle weakness (29.5%), vomiting (20.4%), and dyspnea (15.9%). When ECGs were performed (n = 30), abnormalities were present in 86.7% of cases. Treatment involved administration of insulin (n = 22), sodium/calcium polystyrene sulfonate (n = 14), and/or calcium gluconate (n = 14). Forty patients fully recovered. Three, non-renal impaired, patients passed away. These results offer insight into the clinical aspects of dietary-induced hyperkalemia and suggest that the common assumption that dietary-induced hyperkalemia is a condition of renal impaired patients might be incorrect.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29588531     DOI: 10.1038/s41430-018-0154-6

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  5 in total

1.  Characteristics, Risk Factors, and Adverse Outcomes of Hyperkalemia in Acute-on-Chronic Liver Failure Patients.

Authors:  Jun-Jun Cai; Kai Wang; Hui-Qing Jiang; Tao Han
Journal:  Biomed Res Int       Date:  2019-02-27       Impact factor: 3.411

2.  Surprising Hyperkalemia of 10.2 mmol/L in a Patient with Hyperglycemia: A Case Report.

Authors:  Jan Czogalla; Pischtaz Adel Tariparast; Tobias B Huber; Matthias Janneck; Florian Grahammer
Journal:  Case Rep Nephrol Dial       Date:  2021-02-25

3.  Different Seasonal Variations of Potassium in Hemodialysis Patients with High Longitudinal Potassium Levels: A Multicenter Cohort Study Using DialysisNet.

Authors:  Yunmi Kim; Seong Han Yun; Hoseok Koo; Subin Hwang; Hyo Jin Kim; Sunhwa Lee; Hyunjeong Baek; Hye Hyeon Kim; Kye Hwa Lee; Ju Han Kim; Ji In Park; Kyung Don Yoo
Journal:  Yonsei Med J       Date:  2021-04       Impact factor: 2.759

4.  Assessment of knowledge of drug-food interactions among healthcare professionals in public sector hospitals in eThekwini, KwaZulu-Natal.

Authors:  Emmanuella Chinonso Osuala; Boikhutso Tlou; Elizabeth Bolanle Ojewole
Journal:  PLoS One       Date:  2021-11-03       Impact factor: 3.240

5.  Knowledge, attitudes, and practices towards drug-food interactions among patients at public hospitals in eThekwini, KwaZulu-Natal, South Africa.

Authors:  Emmanuella C Osuala; Boikhutso Tlou; Elizabeth B Ojewole
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.